• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Immunogenicity and efficacy of recombinant 78 kDa antigen of Leishmania donovani formulated in various adjuvants against murine visceral leishmaniasis

    2015-12-23 03:42:47RajeevNagillTejinderKaurJyotiJoshiSukhbirKaur

    Rajeev Nagill, Tejinder Kaur, Jyoti Joshi, Sukhbir Kaur

    Department of Zoology, Panjab University, Chandigarh-160014, India

    Immunogenicity and efficacy of recombinant 78 kDa antigen of Leishmania donovani formulated in various adjuvants against murine visceral leishmaniasis

    Rajeev Nagill, Tejinder Kaur, Jyoti Joshi, Sukhbir Kaur*

    Department of Zoology, Panjab University, Chandigarh-160014, India

    ARTICLE INFO

    Article history:

    Received 15 April 2015

    Received in revised form 20 May 2015

    Accepted 15 June 2015

    Available online 20 July 2015

    Visceral leishmaniasis

    r78kDa

    Liposomes

    MPL-A

    T cell epitope

    Objective: To analyze the protective efficacy of recombinant 78 kDa antigen of Leishmania donovani in combination with two adjuvants, that is, cationic liposomes or MPL-A against visceral leishmaniasis in BALB/c mice. Methods: The genomic DNA of promastigotes was isolated and 583 bp of T cell epitopes of gene encoding 78 kDa was amplified using specific primers. The amplified gene was cloned into pET28c, transformed into Escherichia coli BL21 (DE3) and got expressed after IPTG induction. The recombinant protein was then purified using Ni-NTA and named r78. Three groups of mice were immunized with 10 μg of r78 plus MPL-A, r78 encapsulated in positively charged liposomes and control animals immunized with PBS. Two booster doses were given with the respective vaccine at an interval of 2 weeks each. Mice were challenged with 1×107Leishmania promastigotes and sacrificed on different post infection/challenge days. Results: Immunization with r78 along with MPL-A and liposomeencapsulated r78 brought a significant reduction in parasite load. In comparison to the infected controls, the parasite load declined by 96.2% in mice immunized with r78 plus MPL-A and 97.23% in animals immunized with liposome-encapsulated r78. The immunized animals also exhibited profound DTH response. The serum antibody responses increased from 15 to 90 days post infection/challenge. Immunized animals showed greater IgG2a levels and lesser IgG1 levels in comparison to the infected controls. The splenocytes from immunized mice were cultured, stimulated with r78 and analyzed for cytokine profile. The levels of IL-2 and IFN-γwere greater in immunized animals as compared to control mice. Conclusions: The study proves that r78 in combination with suitable adjuvants is a potential vaccine candidate and may be instrumental in control of visceral leishmaniasis.

    1. Introduction

    The leishmaniases are responsible for the second-highest number of deaths due to parasitic infection globally[1]. They have an overwhelming estimated prevalence of 12 million infected humans, and cause a burden estimated at 2 357 000 disability-adjusted life years[2]. Leishmaniasis has been classified as one of the most neglected diseases, and the estimated disease burden places it second in mortality and fourth in morbidity among the tropical infections[3]. There is no satisfactory chemotherapy for cutaneous leishmaniasis. Existing chemotherapy for visceral leishmaniasis (VL) is, in general, efficient in immunocompetent patients, but is costly and not exempt from side-effects[4]. Resistant strains of Leishmania spp. are emerging, mostly in India[5]. In immunocompromised patients, relapses after therapy are very frequent[6]. To date, several approaches to anti-leishmanial vaccine have been tested. First generation vaccines composed of whole killed parasites have beenproposed. However, most of the vaccine studies concentrate on the second generation vaccines consisting of recombinant proteins, poly-proteins or dendritic cells loaded with peptides derived from leishmanial antigens[1]. For the past 20 years, DNA cloning and characterization of genes encoding parasite proteins suitable for the development of defined vaccines have been carried out[7]. Several native and recombinant antigens, tested in murine models, have shown different degrees of protection[1,8-11]. Recombinant Ldccys1 protein elicits protective immune responses in Leishmania chagasi infected BALB/c mice[12]. BALB/c mice vaccinated with Leishmania major (L. major) Ribosomal Proteins Extracts combined with CpG oligodeoxynucleotides have been reported to become resistant to disease caused by a secondary parasite challenge[13]. Recent studies have shown that subcutaneous vaccination with liposomal rGP63 partially protected susceptible BALB/c mice when challenged with L. major promastigotes[14].

    2. Materials and methods

    2.1. Parasite

    Promastigotes of Leishmania donovani (L. donovani), strain MHOM/ IN/80/Dd8 were grown at ambient temperature of (22±1) ℃ in RPMI-1640 medium supplemented with 10% FCS. The L. donovani strain was maintained by serial subcultures in the same medium after every 48-72 h[15].

    2.2. Animals

    Inbred BALB/c mice of either gender, weighing 20-25 g, were obtained from the Central Animal House of Panjab University, Chandigarh. They were fed with water and mouse feed ad libitum. The ethical clearance to conduct the experiments was obtained from Institutional Animal Ethics Committee, Panjab University, Chandigarh.

    2.3. Preparation of recombinant vaccine

    2.3.1. Isolation of genomic DNA

    Approximately 2×108log phase promastigotes were harvested by centrifugation at 4 000 rpm for 15 min at 4 ℃. The pellet was washed once with PBS (pH-7.2) and finally suspended in the same. Parasite DNA was extracted with the help of genomic DNA extraction kit as per manufacturer’s protocol (Zymo Research, USA). The isolated DNA was quantitated by NanodropTM.

    2.3.2. Designing of primers and PCR amplification of gene fragment encoding 78 kDa

    The T cell epitopes of gene encoding 78 kDa were identified using‘MHC Pred’ online software. The region containing maximum number of T cell epitopes (583 bp) were selected for amplification (Figure 1). The following primers were designed for amplification of 583 bp sequence using IDT ‘Scitools’.

    Forward primer -5’ GCCATATGGGTGCAACAGCTCATCAAGGACT 3’Reverse primer -5’ GATGGATCCGTTCTTCGCTTCGACACGTT 3’

    The restriction enzymes NdeⅠ and BamH 1 were included in the forward and reverse primer sequences respectively for cloning purpose [in pET-28c(+) vector]. PCR was carried out using commercially available kits (Chromous Biotech). Following conditions were used for the amplification of coding region of 583 bp of 78 kDa gene of L. donovani. Initial denaturation was performed at 94 ℃ for 10 min and then for 1 min. Annealing was carried out at 59℃ for one minute. Extension was carried out at 72 ℃ for 1 min and final extension was done at same temperature for ten minutes. PCR was carried out for thirty five cycles.

    2.3.3. Electrophoresis of DNA in agarose gel

    Agarose (0.8%, w/v for genomic DNA and 1%, w/v for PCR product and plasmid) was dissolved in 1×TBE buffer by heating, when it cooled to 50 ℃, ethidium bromide (0.5 μg/mL) was added and the gels were cast in the DNA electrophoresis chamber. After solidification of the agarose, DNA samples containing loading dye buffer (1×) were loaded on to the agarose gel and run in TBE (1×, pH 8.0) buffer. Initially, the gels were run at a constant voltage of 50 V till the dye front left the wells. The voltage was then increased to 100 V. A 2 log ladder (NEB, England) was used as standard DNA marker. The gels were visualized and results recorded on Gel Documentation Unit (Alpha Imager, India).

    2.3.4. Extraction of DNA from preparatory gel

    The PCR product was eluted from preparative agarose gel using gel extraction kit (Geneaid, Taiwan). The eluted DNA was then run on 1% agarose gel.

    2.3.5. Enzymatic digestion and ligation of the vector and PCR products

    Restriction digestions of PCR product and plasmid DNA [(pET-28c(+)] were performed as per the manufacturer’s instructions (MBIFermentas, Germany). The reaction mixture was mixed gently and incubated at 37 ℃. The reaction mixtures were mixed gently and incubated at 37 ℃ for 15 h. The double digested plasmid DNA and PCR products were electrophoresed and purified from the rest of the reaction mixtures with Gel Extraction kit (Geneaid, Taiwan). Ligation reactions were set up using the linearized pET28c and double digested PCR products. The ligation mixture was incubated at 16 ℃ for 16 h in ligation water bath.

    2.3.6. Transformation of recombinant plasmids into Escherichia coli (E. coli)

    The competent E. coli cells were prepared using CaCl2as described by Sambrook and Russell[16]. A loopful of E. coli BL21 (DE3) cells from LB agar plate were inoculated into 10 mL LB and incubated overnight at 37 ℃ with shaking at 180 rpm. From the overnight cultures, 1% inoculum was transferred to fresh LB broth (100 mL) and incubated at 37 ℃ with shaking (180 rpm) till OD600of 0.5 was achieved. The cells were incubated at 4 ℃ for 20 min and harvested by centrifugation at 1 500×g for 15 min at 4 ℃ in a precooled rotor. The supernatant was discarded aseptically and 10 mL of autoclaved and ice cold CaCl2(100 mM) solution was added to the cell pellets. The cells were resuspended by gentle shaking until a homogenous suspension was achieved. The cell suspension was then kept in ice for 30 min and again centrifuged (1 500×g/15 min/4 ℃). The supernatant was discarded aseptically and 2 mL of autoclaved CaCl2(100 mM) was added to the pellet and again resuspended gently. The cells were kept on ice overnight prior to their use. The cells were dispensed into aliquots of 200 μL each. Glycerol stocks (15%) of these cells were prepared and stored at -70 ℃ for subsequent use.

    Transformation efficiency of the competent cells was checked by transforming them with an uncut plasmid and calculating the cfu/μg of DNA. The transformation efficiency of 1×108cfu/μg DNA and above were taken as a good competent cell preparation. Transformation of E. coli BL21 (DE3) cells was carried out as per the instructions given by Sambrook and Russell[16].

    2.3.7. Induction of recombinant 78 kDa (T cell epitope region) expression

    Overnight log phase culture (1%) was transferred to LB+Km50and allowed to grow to OD600of 0.5-0.6 at 37 ℃, 180 rpm before the expression of (His)6tagged region was induced by the addition of IPTG (final concentration of 0.1-1 mM) and incubated at temperatures ranging between 15 ℃ to 37 ℃ for 3-20 h. The induction was then analyzed by SDS-PAGE. The gels were stained for 4 h by standard coomassie brilliant blue R 250 and destained with a methanol (25%)/acetic acid (10%) solution.

    2.3.8. Purification of recombinant 78 kDa (T cell epitope region) protein using Ni-NTA

    For purification of the protein, IPTG induced cells from a 200 mL culture were pelleted, resuspended in lysis buffer (Tris-Cl 50 mM, pH 7.0, NaCl 300 mM, phenylmethylsulfonyl fluorid 1 mM, lysozyme 1 mM and imidazole 10 mM) and sonicated (at 20 kHz, 30 cycles of 10 sec shock followed by 10 sec of rest). After sonication, the cellular debris was removed by centrifugation at 14 000×g for 15 min at 4 ℃. The crude cell extract was loaded onto slurry of nickel-chelating agarose beads 50% (w/v) (2 mL) also equilibrated with the same buffer. The flow through was collected and the column was given washings with 5 column volumes of lysis buffer having imidazole (20 and 30 mM, respectively). Purified recombinant protein was then eluted with lysis buffer amended with imidazole (200 mM). One mL fractions were collected and checked for purified protein on 10% SDS-PAGE. The fractions showing purified protein were then pooled and dialyzed against Tris-Cl (20 mM, pH 7.0) to remove imidazole and NaCl. The purified recombinant protein was then named r78 (Figure 2).

    2.4. In vivo immunization and challenge infection

    BALB/c mice were immunized with 10 μg of purified protein r78 (region coding for T cell epitope only) along with two adjuvants namely monophosphoryl lipid A (MPL-A) (40 μg) and encapsulation in positively charged liposomes. Two booster doses with respective vaccine were given at an interval of 2 weeks each. The control animals were injected with PBS only. 15 days after the last immunization, immunized and control animals were challenged intracardially with 1×107promastigotes of L. donovani.

    2.5. Evaluation of infection

    The animals were sacrificed on 15, 30, 45, 60, 75 and 90 days post infection/challenge and the course of infection was monitored by the microscopic examination of Giemsa-stained impression smears ofliver. The parasite load was assessed in terms of Leishman Donovan Units by the method of Bradley and Kirkley[17].

    2.6. Delayed type hypersensitivity (DTH)

    All groups of mice were challenged in the right foot pad with a subcutaneous injection of leishmanin. Left foot pad was inoculated with PBS. After 48 hours, the thickness of right and left foot pad was measured using a pair of Vernier callipers. Results were expressed as mean±SD of percentage increase in the thickness of the right footpad as compared to the left footpad of mice[18].

    2.7. ELISA

    The specific serum immunoglobulin G (IgG) isotype antibody response was measured by conventional ELISA using commercially available kits (Bangalore Genei, India). 96-well ELISA plates were coated with crude antigen. Serum samples were added at twofold serial dilutions, followed by washes and addition of isotype specific HRP-conjugated secondary antibodies (rabbit anti-mouse IgG1 or IgG2a) after which the substrate and chromogen were added and absorbance was read on an ELISA plate reader at 450 nm[18].

    2.8. Cytokine responses

    The lymphocyte culture was obtained from spleens of immunized BALB/c mice. The cells were isolated and counted, and, after evaluation of their viability by trypan blue exclusion, 1×106cells per well were cultured in RPMI-1640 containing 20 mM NaHCO3, 10 mM HEPES, 100 U of penicillin per mL, 100 μg of streptomycin per mL, 2 mM L-glutamine, and 10% fetal calf serum (complete medium), with 50 μL β-merceptoethanol. The spleen cells were cultured in triplicate in a final volume of 200 μL/well and stimulated with r78 antigen. The culture was incubated for 72 h at 37 ℃in a humified chamber containing 5% CO2. The IL-4, IL-10, IFN-γ and IL-2 levels in the supernatants were determined by sandwich ELISA, according to manufacturer’s instructions (Diaclone, France), after sacrificing all the groups of animals[19].

    2.9. Statistical analysis

    All the experiments were carried out three times independently. All data comparisons were tested for significance by using Student’s t-test; P-values below 0.05 were considered significant. Results were expressed as mean±SD of one of three independent experiments.

    3. Results

    3.1. Parasite load

    Immunization with r78 along with MPL-A (Sigma, USA) and liposome-encapsulated r78 brought a significant reduction in parasite load when compared with infected controls. In comparison to the infected controls, the parasite load declined from 47.0% to 96.2% in case of mice immunized with r78 plus MPL-A while the reduction was 49.00% to 97.23% in animals immunized with liposomeencapsulated r78 (Figure 3A).

    3.2. Delayed type hypersensitivity response

    The animals immunized with r78 along with adjuvants exhibited profound DTH response. Significant increase in footpad thickness was observed in immunized mice as compared to control mice (Figure 3B).

    3.3. Anti-leishmanial antibody response

    The antibody responses increased from 15 to 90 days post infection/ challenge. Immunized animals showed greater IgG2a levels and lesser IgG1 levels in comparison to the infected controls (Figure 4).

    3.4. Vaccine-induced cytokine production

    The splenic lymphocytes from immunized mice were cultured, stimulated with r78 and analyzed for the cytokine profile. The levels of IL-2, IFN- γ, IL-4 and IL-10 secreted by cells were measured by using cytokine assay kit according to the manufacturer’s instructions (Diaclone, France). The levels of IFN- γ and IL-2 were greater in immunized animals as compared to control mice. However the concentration of IL-4 and IL-10 was lesser in immunized animals as compared to the control mice (Figure 5,6).encapsulated r78,* P<0.05.

    4. Discussion

    The treatment options for leishmaniasis are limited and the increased resistance to first line drugs and toxicity of second line drugs makes the development of effective vaccine against the disease highly desirable. Though we say, on the basis of present available data, that there is no effective vaccine against any form of human leishmaniasis, yet, the palpable immunity in a person against reinfection following recovery from the disease strongly gives inkling of the feasibility of vaccination against leishmaniasis[20]. Previously, in our laboratory, we worked on the protective efficacy of 78 kDa antigen of L. donovani against murine visceral leishmaniasis[19]. The antigen was found to be effective against the disease though the protection afforded was not complete. Therefore, in the current study we worked on the recombinant version of the antigen in combination with two different adjuvants: MPL-A and cationic liposomes. The efficacy of the vaccine was tested in terms of parasite burden and generation of immune responses.

    BALB/c mice immunized with r78 alone and in combination with MPL-A or cationic liposomes showed a significant reduction in parasite load as compared to the infected controls. Leastparasite burden was observed in mice immunized with liposomeencapsulated r78. Our results are in consistence with previous studies which showed the efficacy of recombinant proteins against leishmaniasis. Animals immunized with the recombinant protein presented approximately a 100-fold reduction in parasite burden compared to controls that received PBS, BCG or Propionibacterium acnes alone[6]. In contrast to our study where immunization with liposome-encapsulated r78 was slightly more effective in reducing the parasite burden as compared to r78 given along with MPL-A, vaccination with liposomal rGP63 along with MPL-TDM showed almost 2-logfold, and 7–10-log-fold reduction in parasite burden compared to mice boosted with liposomal rGP63 and unvaccinated mice, respectively[21]. However, immunization with recombinant isolates of LeIF, LmSTI1 and TSA from Leishmania braziliensis (L. braziliensis) individually or in combination did not protect mice against challenge infection with L. braziliensis despite the induction of antibody and cell mediated responses[22].

    The humoral responses to the vaccines were characterized by analyzing the distribution of IgG, IgG1 and IgG2a specific antibodies in the serum samples of immunized and control animals. ELISA results showed that immunized groups developed higher level of antibody responses than control animals. The IgG1 response is an indicator of Th2 type of immune response and IgG2a antibody response corresponds to Th1 response which is protective. The immunized animals revealed lesser IgG1 and higher IgG2a responses as compared to the infected controls. Among the immunized groups, the serum antibody levels in mice immunized with liposomeencapsulated r78 and r78 along with MPL-A were comparable.

    A typical DTH reaction is characterized by activation and recruitment predominantly of T cells and macrophages at the site of intradermal injection in previously sensitized host. Peak DTH responses were observed in animals which were immunized with liposome-encapsulated r78 vaccine and these were followed by animals immunized with r78+MPL-A. The immunized mice developed a strong cell-mediated immune response and thereby resisted the challenge by parasites. The results demonstrated a positive correlation between enhanced DTH response and reduced parasite load for all groups.

    The immune response (Th1 or Th2) generated by various vaccine formulations was assessed by quantifying the cytokines (IFN-γ, IL-2, IL-4 and IL-10) produced by splenocytes of vaccinated animals. Immunized animals showed greater IFN- γ and IL-2 levels as compared to the control group. Also, the levels of IL-4 and IL-10 were greater in control animals as compared to the immunized animals. High levels of IFN-γ indicate the development of a protective Th1 immune response. This IFN-γ is found to come from natural killer cells and is thought to play an important role as a component of innate immune mechanism for the activation of macrophages. Similar to our study, rLdccys1 induced a significant secretion of IFN-γ and nitric oxide (NO)[6]. Immunization of mice with recombinant LeIF stimulates the induction of Th1 type immune response with increased production of IFN-γ[23], Similarly, significantly higher levels of IFN-γ and IL-12 were observed in groups of mice receiving rGP63 in presence of liposomes and MPLTDM during prime and boost than mice receiving liposomal rGP63 during boost, after L. donovani challenge infection[21]. While MPL is reported to promote IFN-γ production by Ag-specific CD4+T cells and skewing the immune response towards Th1 type[24], liposomal Ag showed protective response against leishmaniasis[25]. IL-2 plays a critical role in priming naive CD4+T cells to become IL-4 or IFN- γ producers[26] and it is a principal T cell growth factor for Th1 type of immune response. IL-10 represents the main macrophage-deactivating cytokine and plays an important regulatory role in the progression of VL[27]. Our results are in consistence with those obtained from murine leishmaniasis model of both cutaneous and visceral diseases where expression of IFN-γ is associated with control of infection[28,29]. Our results are also in correspondence with the studies which showed that mice immunized with 78 kDa antigen+MPL-A significantly brought down the IL-4 and IL-10 levels in immunized mice[19]. Studies have also shown that immunization with Leish-111f+ MPL-SE protected mice and hamsters against L. infantum infection that correlated with induction of Th1 immune response as characterized with production of IFN-γ, TNF and IL-2 with little IL-4[30]. High levels of IL-10 in infected control animals supported the view that upregulation of this cytokine is accompanied by disease progression and depressed Th1 type of cell mediated immunity with decreased production of IFN-γ and IL-12[31,32]. Previous studies have also confirmed that IL-10 suppresses Th1 response, which plays a protective role against active VL[33]. Moreover studies have shown that IL-10 gene deficient mice are resistant to L. donovani infection and produce more IFN- γ and IL-12 [34].

    In light of these observations, the present study suggests that a recombinant vaccine based on r78 given along with liposomes and MPL-A as adjuvants is protective against experimental murine visceral leishmaniasis and can be further tested in higher animal models to establish its potential as a vaccine candidate against the disease.

    The study proves that r78 in combination with suitable adjuvants is a potential vaccine candidate and may be instrumental in control of visceral leishmaniasis. Further studies are required to explore these vaccines in higher animal models and establish their prophylactic potential.

    Conflict of interest statement

    We declare that we have no conflict of interest.

    Acknowledgements

    The authors acknowledge the support provided by the Indian Council of Medical Research, Department of Health Research, India for providing financial support for this study under project ref. 5/8-7(74)/2005-ECD-Ⅱ.

    [1] Basyoni MM. Leishmania vaccines updates. PUJ 2012; 5: 1-10.

    [2] World Health Organization. Control of the leishmaniases. In: WHO technical report series. Geneva: WHO; 2010, 1–186.

    [3] Bern C, Maguire H, Alvar J Complexities of assessing the disease burden attributed to leishmaniasis. PLoS Negl Trop Dis 2008; 2: 313.

    [4] Guerin PJ, Olliaro P, Sundar S, Boelaert M, Croft SL, Desjeux P, et al. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2002; 2: 494-501.

    [5] Mohapatra S. Drug resistance in leishmaniasis: Newer developments. Trop Parasitol 2014; 4: 4-9.

    [6] Kubar J, Fragaki K. Recombinant DNA-derived Leishmania proteins: from the laboratory to the field. Lancet Infect Dis 2005; 5: 107-114.

    [7] Soto M, Ram?rez L, Pineda MA, Gonzalez VM, Entringer PF, de Oliveira CI, et al. Searching genes encoding Leishmania antigens for diagnosis and protection. Scholarly Res Exchange 2009; 2009: 1-25.

    [8] Das A, Ali, N. Vaccine development against Leishmania donovani. Front Immunol 2012; 3: 99.

    [9] Dumonteil E, Jesus RSM, Javier EO, Del Rosario GMM. DNA vaccines induce partial protection against Leishmania mexicana. Vaccine 2003; 21(17–18): 2170–2177.

    [10] Melby PC, Yang J, Zhao W, Perez LE, Cheng J. Leishmania donovani p36 (LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis. Infect Immun 2001; 69: 4719–4725.

    [11] Ahmed SBH, Touihri L, Chtourou Y, Dellagi K, Bahloul C. DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania major antigens confers full protection in BALB/c mice. Vaccine 2009; 27(1): 99–106.

    [12] Ferreira JHL, Gentil LG, Dias SS, Fedeli CEC, Katz S, Barbieri CL. Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis. Vaccine 2008; 26(5): 677-685.

    [13] Ramirez L, Iborra S, Cortes J, Bonay P, Alonso C, Barral-Netto M, et al. BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge. J Biomed Biotechnol 2010; 2010:181690.

    [14] Jaafari MR, Ghafarian A, Farrokh-Gisour A, Samiei A, Kheiri MT, Mahboudi F, et al. Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB/c mice. Vaccine 2006; 24(29-30): 5708-5717.

    [15] Joshi J, Kaur S. To investigate the therapeutic potential of immunochemotherapy with cisplatin+78kDa+MPL-A against Leishmania donovani in BALB/c mice. Parasit Immunol 2014; 36: 3–12.

    [16] Sambrook J, Russell DW. Molecular cloning: A laboratory manual. 3rd edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA; 2001.

    [17] Bradley DJ, Kirkley J. Regulation of Leishmania populations within host I. the variable course of Leishmania donovani infections in mice. Clin Exp Immunol 1977; 30: 119-129.

    [18] Joshi J, Kaur S. Studies on the protective efficacy of second-generation vaccine along with standard antileishmanial drug in Leishmania donovani infected BALB/c mice. Parasitol 2014; 1-9.

    [19] Nagill R, Kaur S. Enhanced efficacy and immunogenicity of 78 kDa antigen formulated in various adjuvants against murine visceral leishmaniasis. Vaccine 2010; 28: 4002-4012.

    [20] Nagill R, Kau S. Vaccine candidates for leishmaniasis: a review. Int Immunopharmacol 2011; 11: 1464-1488.

    [21] Mazumder S, Maji M, Ali N. Potentiating effects of MPL on DSPC bearing cationic liposomes promote recombinant GP63 vaccine efficacy: High immunogenicity and protection. PLoS Negl Trop Dis 2011; 5(12): e1429.

    [22] Salay G, Dorta ML, Santos NM, Mortara RA, Brodskyn C, Oliveira CI, et al. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World. Clin Vaccine Immunol 2007; 14(9): 1173-1181.

    [23] Skeiky YA, Kennedy M, Kaufman D, Borges MM, Guderian JA, Scholler JK, et al. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile. J Immunol 1998; 161: 6171-6179.

    [24] Baldridge JR, McGowan P, Evans JT, Cluff C, Mossman S, Johnson D, et al. Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and mono therapeutic agents. Expert Opin Biol Ther 2004; 4(7): 1129-1138.

    [25] Mazumdar T, Anam K, Ali N. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice. Vaccine 2004; 22(9-10): 1162-1171.

    [26] Seder RA, Paul WE. Acquisition of lymphokine-producing phenotype by CD4+T cells. Annu Rev Immunol 1994; 12: 635-673.

    [27] Tripathi P, Singh V, Naik S. Immune response to Leishmania: paradox rather than paradigm. FEMS Immunol Med Microbiol 2007; 51: 229-242.

    [28] Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. Reciprocal expression of interferongamma or interleukin duringthe resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med 1989; 169(1):59-72

    [29] Squires KE, Schreiber RD, McElrath MJ, Rubin BY, Anderson SL, Murray HW. Experimental visceral leishmaniasis: role of endogenous IFN-γ in host defense and tissue granulomatous response. J Immunol 1989; 143(12): 4244-4249.

    [30] Coler RN, Goto Y, Bogatzki L, Raman V, Reed SG. Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+T cells. Infect Immun 2007; 75: 4648-4654.

    [31] Carvalho EM, Bacellar O, Barral A, Badaro R, Johnson WD Jr. Antigenspecific immunosuppression in visceral leishmaniasis is cell mediated. J Clin Invest 1989; 83(3): 860-864.

    [32] Ghalib HW, Piuvezam MR, Skeiky YA, Siddig M, Hashim FA, el-Hassan AM, et al. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest 1993; 92: 324-329.

    [33] Carvalho EM, Bacellar O, Brownell C, Regis T, Coffman RL, Reed SG. Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis. J Immunol 1994; 152: 5949-5956.

    [34] Murphy ML, Wille U, Villegas EN, Hunter CA, Farrell JP. IL-10 mediates susceptibility to Leishmania donovani infection. Eur J Immunol 2001; 31: 2848-2856.

    *Corresponding author: Dr. Sukhbir Kaur, Professor, Department of Zoology, Panjab University, Chandigarh-160014, India.

    Tel: +91-172-2541942

    Fax: +91-172-2541409

    E-mail: puzoology@yahoo.com

    Foundation project: It is supported by the Indian Council of Medical Research, Department of Health Research, India for providing financial support for this study under project ref. 5/8-7(74)/2005-ECD-Ⅱ.

    国产一区二区三区综合在线观看| 美女大奶头黄色视频| 日本欧美视频一区| 欧美日韩亚洲高清精品| 亚洲欧美精品综合一区二区三区| 免费久久久久久久精品成人欧美视频| 成人黄色视频免费在线看| 最近中文字幕2019免费版| 亚洲第一青青草原| 十八禁高潮呻吟视频| 99国产精品一区二区三区| 男女高潮啪啪啪动态图| 国产黄色免费在线视频| 母亲3免费完整高清在线观看| 成年美女黄网站色视频大全免费| 人人妻人人澡人人爽人人夜夜| 亚洲第一青青草原| 免费少妇av软件| 侵犯人妻中文字幕一二三四区| 99国产精品一区二区三区| 精品一区二区三区av网在线观看 | 精品一区二区三区四区五区乱码 | 如日韩欧美国产精品一区二区三区| 亚洲欧美一区二区三区黑人| 一级毛片黄色毛片免费观看视频| 亚洲人成77777在线视频| 91精品三级在线观看| 午夜福利一区二区在线看| 久久久精品免费免费高清| 一区福利在线观看| 欧美精品高潮呻吟av久久| 国产欧美日韩一区二区三区在线| 国产欧美日韩一区二区三区在线| 在线观看www视频免费| 国产精品99久久99久久久不卡| av不卡在线播放| 国产精品熟女久久久久浪| 欧美精品啪啪一区二区三区 | 男人操女人黄网站| 纵有疾风起免费观看全集完整版| 丝袜美腿诱惑在线| 亚洲欧美精品自产自拍| tube8黄色片| 亚洲精品一区蜜桃| 国产成人系列免费观看| 免费黄频网站在线观看国产| 男女午夜视频在线观看| 免费在线观看影片大全网站 | avwww免费| 亚洲人成网站在线观看播放| 欧美黑人精品巨大| 一区福利在线观看| 国产精品久久久av美女十八| 精品人妻在线不人妻| 国产淫语在线视频| 一区福利在线观看| 欧美精品高潮呻吟av久久| 国产日韩欧美亚洲二区| 国产高清视频在线播放一区 | 国产精品国产三级国产专区5o| 久热爱精品视频在线9| 亚洲欧美中文字幕日韩二区| 国产精品熟女久久久久浪| www日本在线高清视频| 亚洲精品日本国产第一区| www日本在线高清视频| 亚洲精品日本国产第一区| 黄色视频在线播放观看不卡| 国产精品99久久99久久久不卡| 日韩一区二区三区影片| 国产精品一二三区在线看| 美女视频免费永久观看网站| 悠悠久久av| 婷婷成人精品国产| 国产精品一二三区在线看| 国产无遮挡羞羞视频在线观看| 久久久久久人人人人人| 国产高清视频在线播放一区 | 亚洲欧美日韩另类电影网站| 老司机影院成人| 手机成人av网站| 亚洲一区中文字幕在线| a 毛片基地| 秋霞在线观看毛片| 女人被躁到高潮嗷嗷叫费观| av线在线观看网站| 少妇精品久久久久久久| 久久精品熟女亚洲av麻豆精品| 日韩 欧美 亚洲 中文字幕| 亚洲国产看品久久| 国产一卡二卡三卡精品| 亚洲精品美女久久av网站| www.999成人在线观看| 国产一区二区三区av在线| 伊人亚洲综合成人网| 亚洲精品自拍成人| 久久性视频一级片| 久久精品久久久久久噜噜老黄| 十分钟在线观看高清视频www| 国产一区亚洲一区在线观看| 国产激情久久老熟女| 久久久精品94久久精品| 一级毛片女人18水好多 | 国产精品.久久久| 51午夜福利影视在线观看| 最新的欧美精品一区二区| 成年人黄色毛片网站| 性少妇av在线| 18禁裸乳无遮挡动漫免费视频| 国产片内射在线| 久久国产精品人妻蜜桃| 亚洲精品av麻豆狂野| 无限看片的www在线观看| 亚洲专区国产一区二区| 晚上一个人看的免费电影| 韩国精品一区二区三区| 国产一区有黄有色的免费视频| 国产av一区二区精品久久| 亚洲精品美女久久久久99蜜臀 | 亚洲成人手机| 下体分泌物呈黄色| 亚洲欧美日韩另类电影网站| 午夜视频精品福利| 天天影视国产精品| kizo精华| 亚洲久久久国产精品| 精品人妻熟女毛片av久久网站| 看十八女毛片水多多多| av有码第一页| 老司机影院毛片| 亚洲欧美精品自产自拍| 国产成人影院久久av| 欧美日韩福利视频一区二区| 国产成人免费观看mmmm| www.熟女人妻精品国产| 少妇猛男粗大的猛烈进出视频| 亚洲欧美清纯卡通| 国产精品一区二区精品视频观看| 热re99久久精品国产66热6| 精品人妻一区二区三区麻豆| 日韩电影二区| 黑丝袜美女国产一区| 久久人妻熟女aⅴ| 亚洲精品日韩在线中文字幕| 国产成人av教育| 七月丁香在线播放| 多毛熟女@视频| 啦啦啦中文免费视频观看日本| 老司机深夜福利视频在线观看 | 精品卡一卡二卡四卡免费| 99九九在线精品视频| a级毛片黄视频| 久久精品久久久久久久性| 自线自在国产av| 成人午夜精彩视频在线观看| 久久鲁丝午夜福利片| 国产精品一区二区在线观看99| 亚洲九九香蕉| 亚洲av欧美aⅴ国产| 精品国产乱码久久久久久小说| 成人国产av品久久久| 9191精品国产免费久久| 日韩免费高清中文字幕av| 亚洲国产精品成人久久小说| 久久人人爽人人片av| 少妇粗大呻吟视频| 91成人精品电影| 一区福利在线观看| 19禁男女啪啪无遮挡网站| 国产伦人伦偷精品视频| 在线看a的网站| 丝袜人妻中文字幕| 如日韩欧美国产精品一区二区三区| 亚洲精品乱久久久久久| 国产高清videossex| 啦啦啦视频在线资源免费观看| 国产片特级美女逼逼视频| 国产高清视频在线播放一区 | 一区二区日韩欧美中文字幕| 亚洲av日韩精品久久久久久密 | 狂野欧美激情性xxxx| 91老司机精品| 久久久久网色| 亚洲精品国产av蜜桃| 精品一品国产午夜福利视频| 亚洲精品美女久久av网站| 国产精品国产三级专区第一集| 久久性视频一级片| 爱豆传媒免费全集在线观看| 亚洲国产精品一区三区| 欧美日韩国产mv在线观看视频| 久久国产精品影院| 国产亚洲av片在线观看秒播厂| 18禁国产床啪视频网站| 成在线人永久免费视频| 日日夜夜操网爽| 青春草亚洲视频在线观看| 女人爽到高潮嗷嗷叫在线视频| 一区二区三区激情视频| 亚洲精品久久成人aⅴ小说| 黑丝袜美女国产一区| 十八禁人妻一区二区| 日韩制服骚丝袜av| www.精华液| 少妇猛男粗大的猛烈进出视频| 女性被躁到高潮视频| 91成人精品电影| 欧美人与善性xxx| 婷婷色麻豆天堂久久| 日韩一卡2卡3卡4卡2021年| 欧美日韩视频高清一区二区三区二| 日本欧美国产在线视频| 成人国产一区最新在线观看 | 国产男人的电影天堂91| 热re99久久国产66热| 久久人人爽人人片av| 日本欧美视频一区| 亚洲av日韩精品久久久久久密 | 一级毛片电影观看| 亚洲欧美一区二区三区久久| 日韩中文字幕欧美一区二区 | 亚洲免费av在线视频| 人人澡人人妻人| 老司机影院成人| 亚洲精品国产av蜜桃| 亚洲第一青青草原| 色网站视频免费| 如日韩欧美国产精品一区二区三区| 久久久国产一区二区| 91精品国产国语对白视频| 欧美日韩精品网址| 男女午夜视频在线观看| 看免费成人av毛片| 亚洲av国产av综合av卡| 亚洲国产欧美在线一区| 国产免费视频播放在线视频| 性色av一级| 久久亚洲精品不卡| 女性生殖器流出的白浆| 青草久久国产| 国产人伦9x9x在线观看| 久久精品亚洲熟妇少妇任你| 美女视频免费永久观看网站| 宅男免费午夜| 国产精品久久久久久人妻精品电影 | 另类精品久久| 国产亚洲一区二区精品| 国产在线一区二区三区精| 免费在线观看完整版高清| 亚洲欧美一区二区三区黑人| 精品熟女少妇八av免费久了| 国产日韩一区二区三区精品不卡| 五月天丁香电影| 人人妻,人人澡人人爽秒播 | 国产女主播在线喷水免费视频网站| 欧美日韩福利视频一区二区| www.熟女人妻精品国产| 老司机在亚洲福利影院| 欧美精品高潮呻吟av久久| 岛国毛片在线播放| 婷婷色综合大香蕉| www.精华液| 五月天丁香电影| 波多野结衣av一区二区av| 久久精品人人爽人人爽视色| 一区在线观看完整版| 黄片播放在线免费| 秋霞在线观看毛片| 午夜免费观看性视频| 国产高清不卡午夜福利| 国产精品秋霞免费鲁丝片| 人人妻人人添人人爽欧美一区卜| 超碰成人久久| 国产亚洲av片在线观看秒播厂| 精品久久久久久久毛片微露脸 | 一本一本久久a久久精品综合妖精| cao死你这个sao货| 女人精品久久久久毛片| 国产成人a∨麻豆精品| 久久人人97超碰香蕉20202| 欧美日本中文国产一区发布| 超色免费av| 久久久精品94久久精品| 日韩 亚洲 欧美在线| 亚洲精品久久成人aⅴ小说| cao死你这个sao货| 午夜老司机福利片| 日本av手机在线免费观看| 九色亚洲精品在线播放| www.自偷自拍.com| 黄色视频不卡| 亚洲av国产av综合av卡| 婷婷丁香在线五月| 女性被躁到高潮视频| 涩涩av久久男人的天堂| 久久久国产精品麻豆| 最黄视频免费看| xxxhd国产人妻xxx| 另类精品久久| 午夜福利,免费看| 中国美女看黄片| 中文精品一卡2卡3卡4更新| 热99国产精品久久久久久7| 精品国产一区二区三区四区第35| 狠狠婷婷综合久久久久久88av| 精品国产一区二区久久| 国产免费视频播放在线视频| 狠狠精品人妻久久久久久综合| 成年人午夜在线观看视频| 日韩欧美一区视频在线观看| 成人国产av品久久久| 亚洲欧美一区二区三区久久| www.自偷自拍.com| 视频区欧美日本亚洲| 午夜影院在线不卡| 亚洲精品美女久久久久99蜜臀 | 日韩免费高清中文字幕av| 精品亚洲成国产av| 黑丝袜美女国产一区| av片东京热男人的天堂| 精品少妇久久久久久888优播| 久久精品久久久久久久性| 国产91精品成人一区二区三区 | 中文字幕av电影在线播放| 国产亚洲av高清不卡| 日韩电影二区| 高清黄色对白视频在线免费看| 免费av中文字幕在线| 精品国产超薄肉色丝袜足j| 一本一本久久a久久精品综合妖精| 两性夫妻黄色片| 亚洲精品av麻豆狂野| 午夜精品国产一区二区电影| www.av在线官网国产| 男人操女人黄网站| 亚洲,一卡二卡三卡| 老汉色∧v一级毛片| 五月天丁香电影| 亚洲少妇的诱惑av| 人体艺术视频欧美日本| 桃花免费在线播放| 精品国产国语对白av| tube8黄色片| 国产福利在线免费观看视频| 一区二区av电影网| 亚洲国产最新在线播放| avwww免费| 麻豆国产av国片精品| 看免费av毛片| 啦啦啦啦在线视频资源| 在线精品无人区一区二区三| 国产成人一区二区三区免费视频网站 | 男女无遮挡免费网站观看| 色播在线永久视频| a级片在线免费高清观看视频| 亚洲一码二码三码区别大吗| 丁香六月欧美| 国产色视频综合| 日韩中文字幕视频在线看片| 97人妻天天添夜夜摸| 99re6热这里在线精品视频| 免费在线观看黄色视频的| 免费在线观看视频国产中文字幕亚洲 | 爱豆传媒免费全集在线观看| 欧美人与性动交α欧美软件| 国产成人系列免费观看| 国产成人精品久久久久久| 黑人猛操日本美女一级片| 美女视频免费永久观看网站| 色网站视频免费| 男女高潮啪啪啪动态图| 中文字幕制服av| 男女免费视频国产| 国产人伦9x9x在线观看| videos熟女内射| 亚洲av欧美aⅴ国产| 高清不卡的av网站| 亚洲精品一区蜜桃| 99国产精品一区二区蜜桃av | 无限看片的www在线观看| 80岁老熟妇乱子伦牲交| 成人手机av| 99久久综合免费| 亚洲精品久久成人aⅴ小说| 香蕉国产在线看| 一区二区三区乱码不卡18| 久久毛片免费看一区二区三区| 亚洲美女黄色视频免费看| 国产成人精品久久二区二区免费| 欧美精品高潮呻吟av久久| 免费高清在线观看视频在线观看| 丁香六月欧美| 久久亚洲精品不卡| 精品熟女少妇八av免费久了| 一本久久精品| 1024香蕉在线观看| 国产成人91sexporn| 久久人人爽人人片av| 亚洲成色77777| 2018国产大陆天天弄谢| 999精品在线视频| 少妇裸体淫交视频免费看高清 | 国产精品一区二区在线不卡| 亚洲欧美激情在线| 亚洲国产日韩一区二区| 最新在线观看一区二区三区 | 宅男免费午夜| 日韩一卡2卡3卡4卡2021年| 亚洲欧美一区二区三区国产| 黄色一级大片看看| 国产精品人妻久久久影院| 精品福利观看| 捣出白浆h1v1| 欧美黄色淫秽网站| 精品少妇一区二区三区视频日本电影| 精品人妻熟女毛片av久久网站| 一本—道久久a久久精品蜜桃钙片| 黄网站色视频无遮挡免费观看| 日韩,欧美,国产一区二区三区| 国产一区亚洲一区在线观看| 一二三四在线观看免费中文在| 在线天堂中文资源库| 十分钟在线观看高清视频www| 亚洲欧美日韩另类电影网站| 亚洲av电影在线进入| 国产视频首页在线观看| 自线自在国产av| 欧美xxⅹ黑人| 一区二区三区四区激情视频| 国产xxxxx性猛交| 成人手机av| 精品卡一卡二卡四卡免费| 国产又爽黄色视频| 91国产中文字幕| 咕卡用的链子| 欧美老熟妇乱子伦牲交| 日韩制服骚丝袜av| 日韩 亚洲 欧美在线| 久久久国产精品麻豆| 日本猛色少妇xxxxx猛交久久| 91字幕亚洲| 久久久亚洲精品成人影院| 美女福利国产在线| 久久狼人影院| 性少妇av在线| 蜜桃国产av成人99| 最近最新中文字幕大全免费视频 | 日韩精品免费视频一区二区三区| 一级黄色大片毛片| 日韩精品免费视频一区二区三区| 亚洲色图 男人天堂 中文字幕| 人妻人人澡人人爽人人| 欧美黄色片欧美黄色片| 精品欧美一区二区三区在线| 狠狠精品人妻久久久久久综合| 99国产精品一区二区蜜桃av | 99久久综合免费| 老汉色av国产亚洲站长工具| 久久久久国产一级毛片高清牌| 国产亚洲av高清不卡| 看十八女毛片水多多多| 精品一区在线观看国产| 久久久久久久大尺度免费视频| 又大又爽又粗| av国产久精品久网站免费入址| 亚洲,欧美精品.| 精品欧美一区二区三区在线| 午夜视频精品福利| 亚洲精品日韩在线中文字幕| 一级毛片我不卡| 亚洲国产日韩一区二区| 国产一区亚洲一区在线观看| www.自偷自拍.com| 免费高清在线观看视频在线观看| 成年人午夜在线观看视频| 看十八女毛片水多多多| 成人影院久久| 美女中出高潮动态图| 亚洲av男天堂| 欧美日韩亚洲高清精品| 日韩av不卡免费在线播放| 一本久久精品| 大香蕉久久网| 欧美另类一区| 国产亚洲av片在线观看秒播厂| 日本一区二区免费在线视频| 啦啦啦啦在线视频资源| 美女大奶头黄色视频| 最近手机中文字幕大全| 一二三四社区在线视频社区8| 久久久久精品国产欧美久久久 | 王馨瑶露胸无遮挡在线观看| 91精品三级在线观看| 久久久精品94久久精品| 在线观看一区二区三区激情| 麻豆国产av国片精品| 又紧又爽又黄一区二区| 51午夜福利影视在线观看| 午夜91福利影院| 一二三四社区在线视频社区8| 免费av中文字幕在线| 亚洲第一av免费看| 少妇人妻久久综合中文| 丝袜在线中文字幕| 嫁个100分男人电影在线观看 | 51午夜福利影视在线观看| 亚洲国产欧美网| 亚洲中文av在线| xxxhd国产人妻xxx| 91精品三级在线观看| 青春草亚洲视频在线观看| 亚洲精品久久成人aⅴ小说| 亚洲精品乱久久久久久| 亚洲av成人不卡在线观看播放网 | 麻豆国产av国片精品| 亚洲三区欧美一区| 亚洲一区二区三区欧美精品| 美女国产高潮福利片在线看| 亚洲欧美精品自产自拍| 一级毛片我不卡| 老司机影院毛片| 99久久综合免费| 美女高潮到喷水免费观看| 国产精品一区二区在线不卡| 国产精品国产av在线观看| 丰满人妻熟妇乱又伦精品不卡| av欧美777| 国产精品人妻久久久影院| 男女午夜视频在线观看| 亚洲伊人久久精品综合| 狠狠精品人妻久久久久久综合| 两性夫妻黄色片| 久久国产精品影院| 亚洲国产欧美一区二区综合| 久久久久网色| 国产精品久久久久久人妻精品电影 | 亚洲欧美精品综合一区二区三区| 波野结衣二区三区在线| 日日爽夜夜爽网站| 免费看不卡的av| svipshipincom国产片| 男人添女人高潮全过程视频| 国产激情久久老熟女| 免费少妇av软件| 少妇的丰满在线观看| 国产在线观看jvid| 久久精品久久精品一区二区三区| 精品少妇黑人巨大在线播放| 看免费av毛片| 啦啦啦 在线观看视频| 亚洲 欧美一区二区三区| 亚洲精品美女久久av网站| 91老司机精品| 日本黄色日本黄色录像| 精品少妇久久久久久888优播| 亚洲久久久国产精品| 国产亚洲午夜精品一区二区久久| 男人添女人高潮全过程视频| xxx大片免费视频| 天天躁狠狠躁夜夜躁狠狠躁| 人人妻人人澡人人看| 国产深夜福利视频在线观看| 18禁黄网站禁片午夜丰满| 亚洲av综合色区一区| 青草久久国产| 亚洲精品在线美女| 后天国语完整版免费观看| 亚洲精品中文字幕在线视频| 香蕉国产在线看| 婷婷色av中文字幕| 制服诱惑二区| 久久久久久久大尺度免费视频| 婷婷色综合大香蕉| 男人舔女人的私密视频| 日本wwww免费看| 国产在线一区二区三区精| 亚洲欧洲国产日韩| 男女午夜视频在线观看| 亚洲精品乱久久久久久| 天天影视国产精品| 美女扒开内裤让男人捅视频| 日韩精品免费视频一区二区三区| 又粗又硬又长又爽又黄的视频| 日韩 欧美 亚洲 中文字幕| av网站在线播放免费| 日韩电影二区| 亚洲欧洲日产国产| 精品一区二区三卡| 精品一区在线观看国产| 欧美激情 高清一区二区三区| 日本av手机在线免费观看| 国产精品九九99| 国精品久久久久久国模美| www.av在线官网国产| 午夜日韩欧美国产| 免费观看人在逋| 欧美国产精品va在线观看不卡| 亚洲国产精品一区二区三区在线| 水蜜桃什么品种好| 成人手机av| 午夜精品国产一区二区电影| 一级毛片 在线播放| 久久精品熟女亚洲av麻豆精品| 国产人伦9x9x在线观看| 啦啦啦 在线观看视频| 大片免费播放器 马上看| 欧美xxⅹ黑人| 97精品久久久久久久久久精品| 国产黄色免费在线视频| 丰满饥渴人妻一区二区三| 精品国产乱码久久久久久小说| 午夜免费成人在线视频| 日韩大片免费观看网站| 在线观看免费视频网站a站| 久久影院123|